3'-Deoxy-3'-fluorothymidine
CAS: 25526-93-6
Rif. 3D-ND02399
1g | 621,00 € | ||
50mg | 136,00 € | ||
100mg | 167,00 € | ||
250mg | 283,00 € | ||
500mg | 443,00 € |
Informazioni sul prodotto
- 1-(3-Fluoro-2,3-dideoxy-β-D-ribofuranosyl)thymine1-(3'-Deoxy-3'-fluoro--D-pentofuranosyl)thymine
- 1-(2,3-dideoxy-3-fluoropentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione
- 1-(3'-Deoxy-3'-fluoro-beta-D-pentofuranosyl)thymine
- 1-(3′-Deoxy-3′-fluoro-β-<span class="text-smallcaps">D</span>-pentofuranosyl)thymine
- 1-[(3xi)-2,3-dideoxy-3-fluoro-beta-D-glycero-pentofuranosyl]-5-methylpyrimidine-2,4(1H,3H)-dione
- 3'-Deoxy-3'-fluorothymidine(ALOVUDINE)
- 3'-Fluoro-2',3'-Dideoxythymidine
- 3'-Fluoro-3'-Deoxythymidine
- 3'-Fluoro-thymidine
- 3'-Fluorodeoxythymidine
- Vedi altri sinonimi
- 3'-Fluorothymidine
- 3′-Fluoro-2′,3′-dideoxythymidine
- Alovudine
- Cl 184824
- FLT
- Miv 310
- NSC 140025
- Thymidine, 3'-deoxy-3'-fluoro-
- 3′-Deoxy-3′-fluorothymidine
- 1-(3′-Deoxy-3′-fluoro-β-D-pentofuranosyl)thymine
3'-Deoxy-3'-fluorothymidine is a nucleoside analog that is used to diagnose and treat cancer. It is a prodrug that is metabolized intracellularly by deoxycytidine kinase to the 3'-deoxy-3'-fluoro derivative of thymidine, which competes with natural thymidine for incorporation into DNA. Uptake of 18F-flouride (18F-FDG) in tumor cells has been shown to be proportional to the rate constant (k) of cellular uptake. This process can be quantified using positron emission tomography imaging. The cell cycle inhibitor activity of 3'-deoxy-3'-fluorothymidine has also been demonstrated in vitro and in vivo, inhibiting the proliferation of tumor cells and normal cells in culture, respectively.
Proprietà chimiche
Richiesta tecnica su: 3D-ND02399 3'-Deoxy-3'-fluorothymidine
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.